Nigeria’s pharmaceutical sector has seen high import duties and other barriers weigh heavily on their operations, as they await the implementation of President Bola Tinubu’s executive order whose implementation is facing delays since it was signed over two months ago.
The devaluation of the naira, coupled with high import duties, has significantly increased the cost of procuring essential medical supplies.
Pharmaceutical companies,…
